| 2111 |
Novel amino acid derivatives of naproxen for colon cancer chemoprevention. |
Department of Medicinal Chemistry |
2012 |
| 2112 |
Novel Formulation and Clinical Evaluation of Nalidixic Acid Ointment in Impetigo |
Department of Pharmaceutics |
2012 |
| 2113 |
Novel Formulation and Clinical Evaluation of Nalidixic Acid Ointment in Impetigo |
Department of Pharmaceutics |
2012 |
| 2114 |
Novel Formulation and Clinical Evaluation of Nalidixic Acid Ointment in Impetigo |
Department of Pharmaceutics |
2012 |
| 2115 |
Novel Formulation and Clinical Evaluation of Nalidixic Acid Ointment in Impetigo |
Department of Pharmaceutics |
2012 |
| 2116 |
Novel Schiff Bases of Indoline-2,3-Dione and Nalidixic Acid Hydrazide: Synthesis, In Vitro Antimycobacterial and In Silico Mycobacterium Tuberculosis (Mtb) DNA Gyrase Inhibitory Activity |
Department of Pharmaceutical Organic Chemistry |
2012 |
| 2117 |
Novel Schiff Bases of Indoline-2,3-Dione and Nalidixic Acid Hydrazide: Synthesis, In Vitro Antimycobacterial and In Silico Mycobacterium Tuberculosis (Mtb) DNA Gyrase Inhibitory Activity |
Department of Medicinal Chemistry |
2012 |
| 2118 |
Ocular Drug Deliver and the Importance of Microemulsion as a Potential Delivery System |
Department of Pharmaceutics |
2012 |
| 2119 |
Ocular Drug Deliver and the Importance of Microemulsion as a Potential Delivery System |
Department of Pharmaceutics |
2012 |
| 2120 |
Ocular Drug Deliver and the Importance of Microemulsion as a Potential Delivery System |
Department of Pharmaceutics |
2012 |